Will My Child Need Blood Tests for Seizure Medication?
At a Glance
Blood-test monitoring depends on the medicine. Stable children taking ethosuximide often need little routine testing after baseline checks, while valproic acid usually requires periodic blood counts and liver tests. Serious symptoms need urgent care even if recent results were normal.
In this answer
4 sections
Whether your child needs regular blood tests depends heavily on which medication they are prescribed. For childhood absence epilepsy, two commonly used options—ethosuximide and valproic acid—have very different monitoring requirements [1]. (Note: Other medications, like lamotrigine, are also used depending on whether your child has other seizure types). Ethosuximide generally requires less ongoing blood testing once your child is stable [1]. In contrast, valproic acid usually requires routine blood tests to monitor liver function and blood counts [2]. Because every child’s medical history is different, your pediatric neurologist will create a specific testing schedule that you should follow closely.
Important Safety Note: Never stop or change your child’s antiseizure medication without your neurologist’s advice, as doing so can trigger worsening seizures. However, if your child develops severe symptoms, seek urgent medical care immediately—do not wait for lab results.
At-a-Glance Monitoring Comparison
| Medication | Before Starting (Baseline) | While on a Stable Dose | When to Seek Urgent Care / Blood Tests |
|---|---|---|---|
| Ethosuximide | Often includes baseline blood counts and liver tests (varies by clinic). | Usually relies on clinical check-ins; routine scheduled labs are minimal for most. | New bruising, bleeding, fever, extreme fatigue, rash, or painful joints. |
| Valproic Acid | Baseline complete blood count (CBC) and liver function tests (LFTs) required. | Closer monitoring early in treatment (first few months), then individualized periodic testing. | Jaundice (yellowing eyes), dark urine, repeated vomiting, unusual sleepiness, confusion. |
Ethosuximide: Minimal Routine Monitoring
If your child is prescribed ethosuximide, follow-up care focuses heavily on clinical observation of their seizures rather than an ongoing schedule of laboratory tests [1][3][4]. Practices vary, but after getting initial “baseline” labs to ensure normal blood and organ function, most children on a stable dose do not require frequent routine blood draws [4]. Follow-up may involve occasional EEGs (electroencephalograms—a painless test that measures brain waves), but these are ordered based on seizure control and clinical review, not a strict schedule [1].
While routine monitoring is minimal, ethosuximide can occasionally cause rare but serious hematological (blood-related) issues, such as severe drops in blood cell counts or lupus-like reactions [5][6]. Contact your doctor immediately if your child develops warning signs such as:
- Unusual bruising or bleeding [7][8]
- Unexplained fever or extreme fatigue [5]
- Rash or painful, swollen joints [6]
Valproic Acid: Routine Safety Labs Required
Valproic acid (also called valproate) carries a higher risk for liver toxicity (hepatotoxicity) and blood-related side effects [9][10]. Because of these known risks, baseline and periodic safety testing is standard practice [2]. The risk for liver issues is highest in children under 2 years old, those taking multiple anti-seizure medications, or those with underlying metabolic conditions (like mitochondrial or POLG disorders) [2].
If your child takes valproic acid, they will likely have tests done more frequently during the first few months, followed by an individualized schedule:
- Complete Blood Counts (CBC): Checks red and white blood cells, as well as platelets (the cells that help blood clot) [10][11].
- Liver Function Tests (LFTs): A panel of blood tests to ensure the medication is not stressing the liver [9][2].
When to Seek Immediate Emergency Care
Valproic acid can cause serious liver injury or high ammonia levels in the blood, leading to encephalopathy (a condition affecting brain function) [12][13]. A normal CBC or liver panel does not catch every serious reaction, and a normal valproate level does not rule out high ammonia. Go to an emergency room or seek urgent medical assessment if your child develops:
- Unusual sleepiness (lethargy) or difficulty waking up [13][14]
- Sudden confusion, behavioral changes, or increased seizures [13]
- Jaundice (yellowing of the skin or eyes), pale stools, or dark urine [2]
- Severe or persistent abdominal pain, repeated vomiting, or marked loss of appetite [12][13]
What About Checking Medication Levels?
The doctor may occasionally check the level of either medication in your child’s blood [15][16]. Drug levels are not routinely needed just to check if the dose is “optimal” if your child is doing well. Instead, they are usually ordered to investigate specific concerns, such as:
- Seizures are not well controlled [16]
- Suspected side effects, toxicity, or missed doses [17]
- A change in the medication’s formulation (e.g., switching from a liquid syrup to an extended-release pill) [18]
- Checking for interactions with other medications [15]
If a level is ordered, ask your clinic when the blood should be drawn (usually right before the next dose, known as a “trough” level). Tell the lab the exact time of the last dose, and do not change or skip doses to get the test unless your prescriber explicitly instructs you to do so.
Preparing for Blood Draws
If your child requires bloodwork, ask your clinic about strategies to reduce pain and fear. Many pediatric centers offer numbing creams, distraction tools, or the support of a child life specialist to make the experience easier.
Common questions in this guide
Does every child taking seizure medicine need regular blood tests?
Does ethosuximide require routine blood monitoring?
What blood tests are usually needed with valproic acid?
Which children have a higher risk of liver problems from valproic acid?
What warning signs require urgent care while my child takes valproic acid?
When is a blood level of a seizure medicine checked?
How can I make blood tests less stressful for my child?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What baseline blood tests do you require before my child starts this specific medication?
- 2.If my child is prescribed valproic acid, how frequently will you monitor their liver function and platelet counts during the first few months?
- 3.Who will review abnormal lab results, and how will my family be contacted?
- 4.When you order a medication level to be checked, should the blood be drawn at a specific time, such as right before my child's next dose?
- 5.What emergency after-hours number should I call if my child develops symptoms like unusual sleepiness or persistent vomiting?
- 6.Does my child's age, family history, or other medical conditions increase their risk for side effects on valproic acid?
- 7.What pregnancy-related risks should I be aware of if valproic acid is being considered for my child?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
A Practical Guide to Treatment of Childhood Absence Epilepsy.
Kessler SK, McGinnis E
Paediatric drugs 2019; (21(1)):15-24 doi:10.1007/s40272-019-00325-x.
PMID: 30734897 - 2
The pharmacogenomics of valproic acid.
Zhu MM, Li HL, Shi LH, et al.
Journal of human genetics 2017; (62(12)):1009-1014 doi:10.1038/jhg.2017.91.
PMID: 28878340 - 3
[Childhood absence epilepsy: An update].
Garzon P, Lemelle L, Auvin S
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2016; (23(11)):1176-1183 doi:10.1016/j.arcped.2016.08.005.
PMID: 27683026 - 4
Pretreatment behavior and subsequent medication effects in childhood absence epilepsy.
Shinnar RC, Shinnar S, Cnaan A, et al.
Neurology 2017; (89(16)):1698-1706 doi:10.1212/WNL.0000000000004514.
PMID: 28916534 - 5
Ethosuximide-associated Aplastic Anemia Likely Due to Drug-induced Lupus Erythematosus: A Case Report With Immunologic Insights.
Dcunha NJ, Kwan OA, Sen S, et al.
Journal of pediatric hematology/oncology 2025; (47(3)):131-134 doi:10.1097/MPH.0000000000003011.
PMID: 40013843 - 6
Drug-induced lupus erythematosus in childhood: Case-based review.
Kaya Akca U, Sener S, Batu ED, et al.
Lupus 2024; (33(7)):737-748 doi:10.1177/09612033241245078.
PMID: 38580326 - 7
Ethosuximide-induced Thrombocytopenia: A Case Report.
Shatara M, Regling K, Sabo C, et al.
Journal of pediatric hematology/oncology 2019; (41(5)):420-421 doi:10.1097/MPH.0000000000001310.
PMID: 30212418 - 8
Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report.
Berntson L, Liminga G
Pediatric rheumatology online journal 2022; (20(1)):120 doi:10.1186/s12969-022-00782-8.
PMID: 36550549 - 9
Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy.
Banawalikar N, Adiga S, Adiga U, et al.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica 2021; (54(9)):e11097 doi:10.1590/1414-431X2021e11097.
PMID: 34133540 - 10
Personalized prediction of initial valproic acid dose in children with epilepsy using machine learning techniques.
Zhang Y, Ren S, Yu J, et al.
International journal of clinical pharmacy 2026; (48(3)):992-1003 doi:10.1007/s11096-026-02094-3.
PMID: 41879924 - 11
Analysis of perioperative period coagulation function affected by anti-seizure medications in epilepsy surgery.
Huang Y, Gao D, Dou W
BMC anesthesiology 2025; (26(1)):49 doi:10.1186/s12871-025-03485-1.
PMID: 41408602 - 12
Burst Suppression Pattern on Electroencephalogram Secondary to Valproic Acid-Induced Hyperammonemic Encephalopathy.
Cherian KA, Legatt AD
Pediatric neurology 2017; (73()):88-91 doi:10.1016/j.pediatrneurol.2016.12.011.
PMID: 28545673 - 13
Valproate encephalopathy: Case series and literature review.
Pan C, Zhao Z, Liu Z, et al.
SAGE open medical case reports 2024; (12()):2050313X241260152 doi:10.1177/2050313X241260152.
PMID: 38911175 - 14
Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature.
Raru Y, Zeid F
Respiratory medicine case reports 2018; (25()):1-3 doi:10.1016/j.rmcr.2018.05.026.
PMID: 29872630 - 15
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center.
Biso L, Carli M, Kolachalam S, et al.
Pharmaceuticals (Basel, Switzerland) 2023; (16(7)) doi:10.3390/ph16070945.
PMID: 37513857 - 16
Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy.
Mizuno K, Capparelli EV, Fukuda T, et al.
Clinical pharmacology and therapeutics 2023; (114(2)):459-469 doi:10.1002/cpt.2965.
PMID: 37316457 - 17
UGT1A6 and UGT2B7 Gene Polymorphism and its Effect in Pediatric Epileptic Patients on Sodium Valproate Monotherapy.
Nandith PB, Adiga U, Shenoy V, Adiga M N S
Indian journal of pediatrics 2021; (88(8)):764-770 doi:10.1007/s12098-020-03565-9.
PMID: 33400134 - 18
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients.
Wu C, Zheng J, Pan Y, et al.
Personalized medicine 2025; (22(1)):11-19 doi:10.1080/17410541.2024.2441655.
PMID: 39711059
This page is for informational purposes only and does not constitute medical advice. Your child's pediatric neurologist should decide the testing schedule and guide urgent evaluation for symptoms.
Get notified when new evidence is published on Childhood absence epilepsy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.